These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32155980)

  • 1. Purinergic Receptors: Elucidating the Role of these Immune Mediators in HIV-1 Fusion.
    Freeman TL; Swartz TH
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32155980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.
    Swartz TH; Esposito AM; Durham ND; Hartmann BM; Chen BK
    J Virol; 2014 Oct; 88(19):11504-15. PubMed ID: 25031337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
    Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
    J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.
    Bolduc JF; Ouellet M; Hany L; Tremblay MJ
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion.
    Soare AY; Malik HS; Durham ND; Freeman TL; Alvarez R; Patel F; Satija N; Upadhyay C; Hioe CE; Chen BK; Swartz TH
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative roles of purinergic signaling in human immunodeficiency virus-1 infection.
    Pacheco PA; Faria RX; Ferreira LG; Paixão IC
    Biol Direct; 2014 Oct; 9():21. PubMed ID: 25351961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Integrin α
    Kasarpalkar N; Deb B; Kumar P; Bhor VM
    OMICS; 2020 Jul; 24(7):437-450. PubMed ID: 32522079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
    Compton AA; Bruel T; Porrot F; Mallet A; Sachse M; Euvrard M; Liang C; Casartelli N; Schwartz O
    Cell Host Microbe; 2014 Dec; 16(6):736-47. PubMed ID: 25464829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syncytial apoptosis signaling network induced by the HIV-1 envelope glycoprotein complex: an overview.
    Nardacci R; Perfettini JL; Grieco L; Thieffry D; Kroemer G; Piacentini M
    Cell Death Dis; 2015 Aug; 6(8):e1846. PubMed ID: 26247731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IP-10 Promotes Latent HIV Infection in Resting Memory CD4
    Wang Z; Yin X; Ma M; Ge H; Lang B; Sun H; He S; Fu Y; Sun Y; Yu X; Zhang Z; Cui H; Han X; Xu J; Ding H; Chu Z; Shang H; Wu Y; Jiang Y
    Front Immunol; 2021; 12():656663. PubMed ID: 34447368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships Between HIV-Mediated Chemokine Coreceptor Signaling, Cofilin Hyperactivation, Viral Tropism Switch and HIV-Mediated CD4 Depletion.
    He S; Wu Y
    Curr HIV Res; 2019; 17(6):388-396. PubMed ID: 31702526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine.
    Zaitseva E; Zaitsev E; Melikov K; Arakelyan A; Marin M; Villasmil R; Margolis LB; Melikyan GB; Chernomordik LV
    Cell Host Microbe; 2017 Jul; 22(1):99-110.e7. PubMed ID: 28704658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection.
    Lee DY; Lin X; Paskaleva EE; Liu Y; Puttamadappa SS; Thornber C; Drake JR; Habulin M; Shekhtman A; Canki M
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1231-41. PubMed ID: 20001317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV persistence: chemokines and their signalling pathways.
    Evans VA; Khoury G; Saleh S; Cameron PU; Lewin SR
    Cytokine Growth Factor Rev; 2012; 23(4-5):151-7. PubMed ID: 22749173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step.
    Harmon B; Campbell N; Ratner L
    PLoS Pathog; 2010 Jun; 6(6):e1000956. PubMed ID: 20585556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Host Target Cell Specificity During HIV-1 Infection.
    Council OD; Joseph SB
    Curr HIV Res; 2018; 16(1):13-20. PubMed ID: 29268687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells.
    Wiredja DD; Tabler CO; Schlatzer DM; Li M; Chance MR; Tilton JC
    Retrovirology; 2018 Jul; 15(1):44. PubMed ID: 29970186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery.
    Ran X; Ao Z; Trajtman A; Xu W; Kobinger G; Keynan Y; Yao X
    Sci Rep; 2017 Aug; 7(1):9487. PubMed ID: 28842659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Entry and Membrane Fusion Inhibitors.
    Xiao T; Cai Y; Chen B
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33922579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host and Viral Factors in HIV-Mediated Bystander Apoptosis.
    Garg H; Joshi A
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28829402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.